Drugs

Natural remedies for sore throats include drinking hot beverages or using salt water, lemon juice, licorice root, marshmallow root, apple cider vinegar, or essential oils. Sore throats are an extremely common health ailment, particularly in the winter. A sore throat can be painful and affect daily life due to swelling and inflammation of cells in
0 Comments
Chronic kidney failure, sometimes referred to as chronic renal failure, describes the loss of kidney function over a period of time. There are five stages, each corresponding with a decreasing level of kidney function, with the last stage called end-stage renal disease. In order to make up for the compromised renal system due to kidney
0 Comments
sutimlimab Treatment for Cold Agglutinin Disease (CAD) FDA Issues Complete Response Letter for Sutimlimab, an Investigational Treatment for Hemolysis in Adults with Cold Agglutinin Disease PARIS – November 13, 2020 - The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for sutimlimab, an investigational monoclonal antibody for
0 Comments
KENILWORTH, N.J.–(BUSINESS WIRE) November 13, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, in combination with chemotherapy for the treatment of patients with locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC) whose
0 Comments
6 November 2020 — AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-risk transient ischaemic attack (TIA). The approval by the US Food and Drug Administration (FDA)
0 Comments
An established drug – aprotinin – may present a potential treatment for COVID-19. Since the beginning of the SARS-CoV-2 pandemic, medical researchers across the globe have raced to investigate potential treatments for the novel coronavirus. Treatment of the disease using existing drugs has improved in the last six months, reflected by a decrease in the
0 Comments
ibrexafungerp Treatment for Vaginal Candidiasis Scynexis Announces Submission of New Drug Application to the U.S. Food and Drug Administration for Oral Ibrexafungerp for the Treatment of Vaginal Yeast Infection JERSEY CITY, N.J., Oct. 14, 2020 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections,
0 Comments
FDA Approves Sutab (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets for Colonoscopy Preparation BRAINTREE, Mass., Nov. 10, 2020 /PRNewswire/ — Sebela Pharmaceuticals® today announces that the U.S. Food and Drug Administration (FDA) approved Sutab® (sodium sulfate, magnesium sulfate, and potassium chloride) tablets. Sutab, a sulfate-based tablet preparation for colonoscopy, was developed and will be
0 Comments
Clinical trial reports six and a half month longer survival in patients who were treated with new treatment for ALS. Amyotrophic lateral sclerosis or ALS is a progressive nervous system disorder that affects nerve cells in the brain and spinal cord, causing muscle weakness and loss of control. It is also known as Lou Gehrig’s
0 Comments
Researchers investigated the influence of daily solar irradiation on the seasonal patterns of respiratory viral epidemics in temperate regions. It is well known that many respiratory viral epidemics, such as influenza, develop during autumn and winter in northern and southern hemisphere temperate regions. On the other hand, in equatorial regions respiratory viral epidemics are present
0 Comments
Treatment for Migraine Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta FREMONT, Calif., Oct. 21, 2020 (GLOBE NEWSWIRE) – Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, announced today that it has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) in connection with the Qtrypta™ (zolmitriptan transdermal microneedle system) 505(b)(2) New Drug Application
0 Comments
Study finds beetroot peptide may be useful in developing anti-inflammatory drugs. Plants have been used for medicinal purposes for centuries. Almost 50% of drugs have been developed from natural products. For example, aspirin is derived from willow bark, and the anti-cancer drugs vinblastine and vincristine were developed from the rosy-periwinkle flower. Other important life-saving drugs
0 Comments
November 9, 2020 Audience: Consumer, Patient, Health Professional, Pharmacy November 09, 2020 — Lohxa, LLC is voluntarily recalling Chlorhexidine Gluconate Oral Rinse USP, 0.12% Alcohol free (NDC:70166-027-15) products bearing an expiration date from 01/31/21 – 03/31/21 (see specific lots below) to the consumer level. This product is sourced and repackaged from Sunstar Americas Inc. who
0 Comments
A recent research study states that large COVID-19 outbreaks in European nursing homes have skewed COVID-19 death data for older age groups. This renders cross-country comparisons of the pandemic’s scale inaccurate. Inconsistent data makes estimating the size and infection severity of the coronavirus pandemic a challenge. COVID-19 death rates are often used as an essential
0 Comments
FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. Food and Drug Administration (FDA) has approved Sesquient (fosphenytoin sodium for injection) for the treatment of status epilepticus in adult
0 Comments
Early research suggests that fitness trackers can predict COVID-19 by tracking changes in a person’s activity. One of the keys to preventing the spread of SARS-CoV-2 – the virus responsible for the COVID-19 illness – is quick identification, tracing and isolation of cases before it can be spread further to others. This has been particularly
0 Comments
A recent worldwide study examined the relationship between personality factors and compliance with shelter-in-place orders during the coronavirus. As countries around the world battle the second wave of the coronavirus, and self-isolation fatigue is becoming an increasingly alarming issue, understanding how compliance with social distancing can be influenced by different factors is as important as
0 Comments
November 2, 2020 Audience: Consumer, Health Professional, Pharmacy November 02, 2020 — Kansas City, Missouri, Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 750 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg have been found to contain levels of nitrosamine impurities
0 Comments
A recent study breaks down the ideal balance of activities for children’s bone health. Today, osteoporosis, a disease resulting in the loss of bone mass, is the leading cause of weakness and fractures in adults. Globally, 200 million people are affected by osteoporosis, 75 million of which are seen in Japan, Europe, and USA. Proper
0 Comments
Fecal immunochemical tests may improve diagnostic pathway for colorectal cancer. Bowel symptoms are an imprecise indicator of colorectal cancer (CRC). Essentially the bowel symptoms produced by colon cancer can also be caused by a range of other conditions. However, such is the seriousness of bowel cancer that when symptoms are present, patients will usually be
0 Comments
News FDA Alerts Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit November 3, 2020 Audience: Consumer, Health Professional, Pharmacy November 03, 2020 — Nostrum Laboratories, Inc. is notifying its distributors by letter and is arranging
0 Comments
A new study published in the Journal of Hospital Medicine provides insight into COVID-19 death rates over time.  Since the start of the COVID-19 pandemic, the number of infected individuals has been growing followed by increases in mortality. Initially, New York was one of the hardest hit cities and medical personnel prepared for the continuation
0 Comments
BOSTON–(BUSINESS WIRE)–Oct. 12, 2020– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvz) 100 mg/mL formulation for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH) and for atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy for adult and pediatric (one month of age and
0 Comments
FDA Approves Bronchitol (mannitol) Inhalation Powder to Improve Pulmonary Function in Adult Patients with Cystic Fibrosis CARY, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) — Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), received U.S. Food and Drug Administration (FDA) approval of Bronchitol (mannitol) inhalation powder. Bronchitol
0 Comments
PLYMOUTH MEETING, PA and CHICAGO, IL, October 13, 2020 — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the U.S. Food and Drug Administration (FDA) has approved Wakix (pitolisant) for the treatment
0 Comments